Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When and how to treat hyperlipidemia.

P T Kuo

    Primary Care
    |March 1, 1985
    PubMed
    Summary

    Hyperlipidemia is a major risk factor for coronary artery disease (CAD). Controlling hyperlipidemia through diet and medication significantly reduces cardiovascular disease (CVD) incidence and complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Are the floral morphology and anatomy of Galphimia australis, an atypical neotropical Malpighiaceae, associated to a new pollination syndrome?

    Protoplasma·2022
    Same author

    The Relationship of the Degree of Lipemia to the Blood Cells and Oxygen Tension of the Tissues of the Legs.

    Transactions of the American Clinical and Climatological Association·2011
    Same author

    [The blood prothrombin level in pulmonary tuberculosis].

    Zhonghua yi xue za zhi·2010
    Same author

    Treatment of empyema by aspiration and chemotherapy.

    Chinese medical journal (Peking, China : 1932)·2010
    Same author

    Comparative push-out test of dense HA implants and HA-coated implants: findings in a canine study.

    Journal of biomedical materials research·1998
    Same author

    Dyslipidemia and coronary artery disease.

    Clinical cardiology·1994

    Area of Science:

    • Cardiovascular Medicine
    • Metabolic Disorders
    • Preventive Cardiology

    Background:

    • Coronary Heart Disease (CHD) prevention trials are crucial for understanding cardiovascular risk factors.
    • Hyperlipidemia, characterized by elevated cholesterol and triglycerides, is a primary focus in cardiovascular research.

    Observation:

    • The NHLBI-sponsored Coronary Heart Disease Prevention Trial provides definitive evidence linking hyperlipidemia to increased CAD risk.
    • Diet-drug therapy effectively manages hyperlipidemia, leading to favorable modifications in CHD incidence and complications.
    • Atherosclerotic lesions can be stabilized or regressed through effective hyperlipidemia control.

    Findings:

    • Simple differentiation of hyperlipidemias (hypercholesterolemia, hypertriglyceridemia) is often sufficient for clinical management.
    • Lipoprotein analysis aids in managing difficult hyperlipidemias by identifying genetic-metabolic abnormalities.
    • Excluding secondary hyperlipidemias is essential before initiating hypolipidemic therapy.

    Implications:

    • Lifelong dietary modification is fundamental for treating all hyperlipidemias, especially primary forms.
    • Patient and family education on dietary changes is vital for compliance in primary hyperlipidemias.
    • Early detection and management of hyperlipidemia in children and young adults are critical for long-term cardiovascular health and healthcare cost reduction.

    Related Experiment Videos